amyloidosis gelsolin
The ability of the PCR technique to amplify DNA molecules 109-fold permits the analysis of DNA sequence variations in single cells [1] . Consequently, genotyping of individual sperm cells has provided a new approach for genetic mapping (for a review, see ref. 2) , and the analysis of blastomeres from in vitro-fertilized (IVF) embryos has been utilized in preimplanta-tion diagnosis [3] 5 So far, preimplantation diagnosis has most frequently been used for the sex determination of embryos at risk of X-linked disorders [3, 4] , but also for a few autosomally inherited disorders, such as (3-thalassemia, cystic fibrosis, and Tay-Sachs disease [5] [6] [7] . We undertook this study because of the evident need for preimplantation diagnosis in Finland, where >30 mostly recessively inherited severe disorders, only rarely encountered in other populations, have been enriched [8] . We chose as targets rwo recessively inherited disorders, aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL), and one dominantly inherited disorder, familial amyloidosis of the Finnish type [FAF, or gelsolin (GSN)-related amyloidosis], because the disease-causing mutations have been identified in these disorders, and their routine DNA diagnosis is well established [9] [10] [11] . No specific cure is available for these disorders, so prevention through genetic counseling and early prenatal diagnosis is so far the only measure available. In addition to the mutations causing AGU, INCL, and FAF, seven polymorphic nucleotides on different human chromosomes were analyzed from granulosa cells and blastomeres to develop a generally applicable procedure for detecting mutations in single cells. We combined the method for whole-genome amplification, known as primer extension preamplification (PEP) [12] , with a singlePCR amplification using locus-specific primers,followed by detection of the mutation with a solid-phase minisequencing method [13] . PEP amplification involves multiple rounds of annealing and extension of a mixture of short, random (e.g., l5-mer) oligonucleotide primers and has been shown to be a promising tool for genetic analysis of single cells in several recent studies [7, 14, 15] . The solid-phase minisequencing method detects point mutations in DNA fragments amplified by [16] . Using the procedure developed in this study, we reproducibly and efficiently amplified a highly repre-
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sentative part of the genome and identified the correct genotype in the majority of the cells analyzed.
Materials and Methods
SAMPLES
All samples were collected with permission from the Ethical Committee of the Family Federation of Finland. Human granulosa cells were isolated from the cumulus oophorus surrounding the oocyte. The cells were isolated as a byproduct in the preparation of the oocytes in intracytoplasmic sperm injection, as described in detail previously [17] . Briefly, the oocytes surrounded by the cumulus oophorus were collected and cultivated for 1-2 h in Medicult Universal 1VF medium, and treated with IVF medium containing 80 U of hyaluronidase enzyme (Type 1V-S; Sigma Chemical Co., St. Louis, MO). After separation of the oocytes, the single granulosa cells were rinsed with culture medium without enzyme. The singlegranulosa cells primer was 5'-GCATCTCTGAGCCACTGCCC.
The primers were synthesized on an Applied Biosystems (Foster City, CA) 392 DNA synthesizer.
PROCEDURES
Prevention of contamination. To avoid contamination,
we carried out the PEP and PCR amplifications in laboratories located in separate buildings. DNA-free reagents and equipment were used, and the amplification reactions were set up by using positive-displacement pipettes in hoods equipped with an ultraviolet light. Samples of the cell medium, lysis and neutralization solutions, and water were included in each amplification experiment to confirm the absence of contaminating DNA. The PCR products were analyzed in a laboratory physically separated from the PCR laboratory.
PEP. The genome of the lysed single cells was amplified for 50 cycles of 1 mm at 92 #{176}C, 2 mm at 37 #{176}C, a ramping step of 10 s/#{176}C to 54#{176}C, and 4 mm at 55 #{176}C. Random degenerate 15-mer primers at 33 moVL were used in accordance with the PEP procedure described by Zhang et al. [12] , with the followingtwo modifications:
We increased the pH of the PEP buffer (2.5 When genomic DNA samples were amplified, KC1 was added to the PEP buffer to give a final concentration of 50 mmol/L. After PEP, the 60-pL samples were divided into 5-jiL aliquots and stored at -20 #{176}C until further use or kept at 0 #{176}C and analyzed immediately. The amplification reactions were carried out for 40 cycles of 1 mm at 94 #{176}C, 1 mm at a temperature optimal for the primer pair (58 #{176}C for loci 3BHSD, PROSI, IGF2, TP53, and GSN; 54 #{176}C for ADH3 and ARSB; 62 #{176}C for C3; 55 #{176}C for AGA and 52 #{176}C for PPT), and I mm at 72 #{176}C in a programmable heat block. The correct size of the PCR products, ranging from 75 to 226 bp, and the quality of the PCR products were initially assessed by electrophoresis in 2% agarose gels.
Solid-phase minisequencing.
To in advance, and that R always differs by at least 10-fold from that obtained in homozygous samples at the same locus, the interpretation of the results is unequivocal. The R value is proportional to the ratio between two amplified alleles, even when they are present in ratios other than homozygous (2:0) and heterozygous (1:1).
Results
OPTIMAL PROCEDURE
Many preliminary experiments, in which genomic DNA was diluted to the level of single copies, were carried out to determine the most efficient procedure.PCR amplification with primers specific for the GSN gene was followed by detection of the nucleotide (G) at position 654 by the solid-phase
. We found that PEP with a random mixture of 15-mer primers [12] , followed by a single PCR with specific primers for 40 cycles, reproducibly yields a sufficient amount of product to generate a positive signal of > 1000 cpm in the minisequencing reaction from a single copy of the diploid genome.
Less efficient was a modified PEP procedure in which random 6-mer primers and two-phase amplification [31] were used for a total of 50 cycles; this procedure required 50 copies of the genome for a positive signal after a single locus-specific PCR. A similar result to that obtained with random 15-mer primers in the PEP was obtained with GSN-specificprimers in two consecutivePCRs, each for40 cyclesand each with a heminested primer in the second amplification. An obvious advantage of whole-genome amplification as compared with two specific PCRs with nested primers is that the former yields material for several independent PCR amplifications with locus-specific primers. Therefore, the procedure used in all further experiments consisted of amplification of the genome of the single cells by PEP with 15-mer primers, followed by a single PCR amplification with locus-specific primers and detection of the variable nucleotide by the solidphase minisequencing method. The steps of the optimal procedure are illustrated in Fig. 1 .
GENOTYPING OF JO LOCI FROM SINGLE GRANULOSA CELLS
Granulosa cells were chosen as the model cells for evaluating the method. These cells surround the ovum and are easily isolated (after collection of ova) by a method similar to that used in the separation and analysis of single blastomeres. amount of PCR product in the second amplification was obtained from the single granulosa cells at 100 of the 102 loci analyzed, indicating that a representative part of the genome had been amplified by the PEP procedure. By reamplifying with specific primers dilutions of the PCR products corresponding to the two negative samples, we found that the reason for the negative result was failure of the PEP. At the six loci for which the individual had been shown to be homozygous, the genotype of the single cells was unequivocally homozygous at all loci at which a PCR product was obtained ( Table 2) .
Interestingly, we observed differences in the relative amounts of the two alleles amplified at each of the four heterozygous loci. To clarify the reason for these different allele ratios (Table 2) , we repeated the minisequencing analysis of the PCR-amplified ARSB locus for four samples (cells 1, 3, 5, and 7) that had shown particularly large differences in R values (Table 3, experiment 2). PCR amplification with the primers specific for the ARSB locus was also repeated from the initial PEP amplification product of these cells; this was followed by the minisequencing assay (Table 3 , experiment 3). The differences in R values between the cell samples obtained in the first analysis (Table 3,  experiment 1) remained unaltered in these two experiments (F 0.055; P = 0.947) [32] , which shows that the reason for the different allele ratios is random variation in the efficiency of the PEP amplification between the two alleles. Possible introduction of mutations during PEP by the degenerate primers was excluded by carrying out a minisequencing assay for the two other nucleotides (C and 'T); neither was detected at the site of the variable nucleotide in the ARSB gene. In cell 1 at the ARSB locus and in cells 4 and 6 at the IGF2 locus ( Table  2) , preferential amplification of one of the alleles during the PEP procedure would have resulted in mistyping of the heterozygous sample as homozygous, according to the stringent criterion of 10-fold differences in R values between the genotypes.
DETECTION OF THREE DISEASE-CAUSING MUTATIONS IN GENOMIC DNA
As shown in Table 2 , the normal nucleotide at the position of the mutation in the PPT, AGU, and GSN genes was reproducibly identified from single granulosa cells. To ensure that the actual disease-causing mutation was also detected, we analyzed genomic DNA isolated from INCL and AGU patients homozygous for the respective mutations, from INCL and AGU carriers, and from a patient heterozygous for the FAF mutation.
Samples containing 7 and 70 pg of genomic DNA, corresponding to -1-and 10-diploid genome equivalents, respectively, were amplified by PEP. The mutant and normal nucleotides were correctly identified in all homozygous DNA samples (Table 4) . Also in this experiment, we observed variations in the ratios between the amplified alleles in the heterozygous samples. Preferential amplification of the mutant allele in one of the samples from an 1NCL carrier would have resulted in mistyping of this sample as homozygous mutant. The variation in R values in this experiment could also result from stochastic pipetting errors that may have occurred when diluted DNA samples containing low copy numbers of the genome were added to the PEP amplification reaction mixtures.
ANALYSIS
OF BLASTOMERES FROM A HUMAN EMBRYO
Finally, after successful detection of the GSN and AGA genes in single murine blastomeres with primers for the mouse GSN and AGA genes, respectively (data not shown), four single blastomeres isolated from a four-cell-stage human embryo were analyzed. Primers specific for the human PPT, AGA, and GSN genes and for the seven polymorphic loci were used. A signal in 
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a The data from Experiment 1 are those presented in Table 2 . Experiment 2 was a separate minisequencing assay of the same PCR product as in Experiment 1. Experiment3 was a separate PCRand minisequencingassay performed with the initial PEP product.
b Cpm incorporated; means of duplicate minisequencing assays.
Control 2 was a lysate of several thousand granulosa cells subjected directly to PCR without PEP. 
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Clinical Chemisiiy 42, No. 9, 1996 1387 the minisequencing assay was generated at all amplified loci (Table 5 ).According to the R values obtained, the cells of the embryo appeared, as expected, to be homozygous for the normal nucleotide in the PPT, AGA, and GSN genes, and also at the ADH3, TP53, and C3 loci. The R valuesalsoshowed thatthe embryo was heterozygous for the polymorphism at the 3BHSD, PROS1, ARSB, and IGF2 loci, but again variations in the relative amount of the amplified alleles were observed. In blastomere 2, the embryo would have been typed as homozygous for nucleotide G at the ARSB locus, whereas the embryo was clearly heterozygous at the ARSB locus in the three other blastomeres.
Discussion
Preimplantation diagnosis of IVF embryos offers a relevant alternative to conventional prenatal diagnosis of couples at risk of conceiving a child with a difficult hereditary disorder that has a well-characterized molecular genetic background. We report here a procedure generally applicable for the analysis of single blastomeres potentially carrying disease-causing mutations. The technique comprises whole-genome amplification by PEP with random 15-mer primers [12] , a single PCR amplification with locus-specific primers, and identification of the mutation by a solid-phase minisequencing method [13] . By successful analysis of human singlegranulosa cellsand blastomeresat 10 lociin coding regions on different chromosomes, we showed that a highly representative part of the genome was amplified by PEP. PEP failed to yield a product that was amplifiable by the locus-specific PCR in only 2 cases out of 146. Surprisingly, our procedure, which is based on a single specific PCR amplification of the PEP product, was equally or even more specific and sensitive than most previously described procedures for PEP-based single-cell analyses, which utilize nested or heminested primers in a second specific PCR amplification (7, 14, 15] . In our experience, -100-1000 copies of the genome are required to detect a variable nucleotide from genomic DNA by a single PCR for 40 cycles and solid-phase minisequencing.
Assuming equal efficiency of the PCR for PEP products and genomic DNA, and taking into account that 1/12 of the PEP product was amplified by the specific PCRs, we estimate that PEP amplification generated at least 1000 copies of the genome. This figure is much larger than the frequently cited estimate by Zhang et al. [12] , according to which PEP amplification yields with 78% probability at least 30 copies of any sequence of the genome from a haploid cell. The notion that substantially more than 30-60 copies of the diploid genome were generated by PEP amplification is supported by a calculation based on the following: In the solid-phase minisequencing method, sequence variants are distinguished by using a DNA polymerase to specifically extend the 3' end of a primer that has been annealed immediately upstream of a variable nucleotide position. The reaction is highly specific, allowing unequivocal genotyping at any variable position. Because the assay is carried out in a solid-phase format, the results are directly obtained as objective numeric R values, which define the genotype of the samples. At all analyzed homozygous nucleotide positions, the correct genotype was identified, indicating that mutations are not introduced by the random primers used for the PEP amplification.
The absence of mutations introduced by the PEP primer was also demonstrated experimentally by analyzing all four nucleotides by the solidphase minisequencing method at two loci. Furthermore, the solid-phase minisequencing method is a particularly favorable tool for determination by PCR of the ratio between two sequences (e.g., alleles) that differ from each other by a single nucleotide and are present as a mixture in a sample. Because the two sequences are essentially identical, they are amplified with equal efficiency regardless of whether the PCR amplification is in its exponential phase or not [34] . Therefore, our method avoids the preferential amplification of one of the alleles in a heterozygous sample, which has been shown to occur during PCR because of differences in size or sequence of the allele [35] .
In the present study, the solid-phase minisequencing method revealed uneven distribution between the alleles in the final PCR product at all heterozygous loci analyzed. As could be expected, and as was shown experimentally, this variation in ratios between the alleles originates from the PEP, presumably by uneven amplification of the alleles during the initial PEP cycles, where only a few copies of the genome are present, and not from the PCR with locus-specific primers. as <1% of a sample [9, 36] . The rate of correct genotyping of single cells by the present procedure can thus be further improved by applying less stringent criteria for defining the genotypes, which is feasible in practice after the method has been carefully standardized for the particular nucleotide position to be analyzed.
In a study in which fluorescent PCR products amplified from single cells were detected with high sensitivity by a DNA-sequencing instrument, Findley et al. clearly showed that the problem of preferential amplification of one allele was substantially less than in conventional, lesssensitive detection methods [37] . A drawback of detecting PCR products with a DNA sequencer is that the method can only be used for sex determination or for detecting mutant alleles that differ in size from the normal allele (e.g., the alleles carrying the cystic fibrosis z-F508 deletion mutation) and not for detecting point mutations.
The risk of mistyping a heterozygous sample as homozygous because of preferential amplification of the normal allele during PEP is a serious problem in the preimplantation diagnosis of dominantly inherited disorders because failure to detect the disease-causing allele would result in a false prediction of the health status of the embryo. The same problem can be encountered in recessive disorders caused by compound heterozygous mutations. However, the problem can be overcome by analyzing two individual cells from the same embryo, which greatly increases the probability of correct genorvping. The procedure developed in this study has several advantages in clinical practice. The use of a single, specific PCR amplification after PEP instead of two consecutive PCR amplifications, as used in previous PEP-based methods developed for single-cell analysis [14, 15] , reduces the time required for the analysis. Also, a single PCR amplification reduces the risk of DNA contaminations by minimizing the number of manipulations of the samples. Prevention of contamination is of crucial importance, especially in preimplantation diagnosis, where single cells are analyzed and the analysis cannot be repeated. In the future, the risk of contamination associated with methods based on DNA amplification may be avoided by using methods that detect the mutations directly from blastomeres by fluorescence in situ hybridization (FISH). So far, diagnosis of single cells by FISH has been applied to X-linked disorders, where determination of the sex of the embryo and transfer female embryos can be used only as a preventive tool [38] . Detection of single-nucleotide variations by FISH will require the development of probes with more-sensitive labels and higher specificity than those available today; e.g., the recently devised "padlock" probes are promising [39] . Finally, the solid-phase minisequencing method can be applied for the detection of all disease-causing mutations under the same reaction conditions.
In this study, we detected singlenucleotide changes, but the method can be designed for the identification of both small and large deletions.
We conclude that whole-genome amplification by PEP followed by identification of the disease-causing mutation by the solid-phase minisequencing method is feasible for preimplantation diagnosis; however, the risk of preferential amplification of one of the alleles has to be considered in the diagnosis of dominantly inherited disorders and of recessive disorders caused by compound heterozygous mutations. The possibility of false genotyping can be decreased by analyzing two individual cells from the same embryo at the eight-cell stage and by standardization of the solid-phase minisequencing method to allow reliable detection of a small minority of the mutant sequence in the presence of a vast excess of the normal sequence. Consequently, the procedure developed here can be used not only for preimplantation diagnosis of recessive disorders in an isolated population but also for a wide range of hereditary diseases that have been characterized at the molecular level. Obviously, our procedure will also be highly useful for genotyping multiple loci from samples containing a limited number of cells in applications other than preimplantation diagnosis.
We 
